| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CEP350 AKAP5 ANK2 MAP1A EML4 CAPN6 KIF16B CLSTN1 TNNT3 SPATA32 DYNC1I1 IQGAP1 | 1.01e-05 | 1099 | 49 | 12 | GO:0008092 |
| GeneOntologyMolecularFunction | molecular adaptor activity | AKAP5 HDAC5 ANK2 MAP1A NACA KAT6A KSR2 HIPK2 SMARCE1 SRCAP STX16 AKAP12 IQGAP1 | 1.61e-05 | 1356 | 49 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | HDAC5 ANK2 MAP1A NACA KAT6A KSR2 HIPK2 SMARCE1 SRCAP STX16 AKAP12 IQGAP1 | 1.74e-05 | 1160 | 49 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | microtubule binding | 1.03e-04 | 308 | 49 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.23e-04 | 104 | 49 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 4.52e-04 | 13 | 49 | 2 | GO:0005078 | |
| GeneOntologyMolecularFunction | tubulin binding | 6.00e-04 | 428 | 49 | 6 | GO:0015631 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 6.93e-04 | 16 | 49 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 8.59e-04 | 303 | 49 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 9.28e-04 | 78 | 49 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.04e-03 | 81 | 49 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.54e-03 | 93 | 49 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.57e-03 | 24 | 49 | 2 | GO:0008093 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.01e-03 | 102 | 49 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.28e-03 | 753 | 49 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.38e-03 | 229 | 49 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.42e-03 | 562 | 49 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.74e-03 | 238 | 49 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | spectrin binding | 3.15e-03 | 34 | 49 | 2 | GO:0030507 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 3.66e-03 | 126 | 49 | 3 | GO:0051082 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 3.91e-03 | 129 | 49 | 3 | GO:0035591 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase A signaling | 2.16e-05 | 23 | 49 | 3 | GO:0010738 | |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 5.36e-05 | 5 | 49 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | postsynaptic density | 8.15e-05 | 451 | 49 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | postsynapse | CHRNA6 AKAP5 ANK2 MAP1A SRGAP3 ANKS1B GRIN2B CLSTN1 USP48 ADAM22 | 1.04e-04 | 1018 | 49 | 10 | GO:0098794 |
| GeneOntologyCellularComponent | dendritic branch | 1.12e-04 | 7 | 49 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.16e-04 | 477 | 49 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.60e-04 | 503 | 49 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.04e-04 | 523 | 49 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.07e-04 | 49 | 49 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 3.07e-04 | 56 | 49 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.52e-04 | 405 | 49 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.93e-04 | 583 | 49 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | microtubule | 1.47e-03 | 533 | 49 | 6 | GO:0005874 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.49e-03 | 1179 | 49 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.56e-03 | 1187 | 49 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | postsynaptic endosome | 1.69e-03 | 26 | 49 | 2 | GO:0098845 | |
| GeneOntologyCellularComponent | axon initial segment | 2.10e-03 | 29 | 49 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | dendritic spine | 2.47e-03 | 242 | 49 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 2.66e-03 | 247 | 49 | 4 | GO:0044309 | |
| Domain | Pkinase-A_anch_WSK-motif | 6.47e-06 | 2 | 48 | 2 | IPR001573 | |
| Domain | WSK | 6.47e-06 | 2 | 48 | 2 | PF03832 | |
| Domain | EGD2/NACA | 1.94e-05 | 3 | 48 | 2 | IPR016641 | |
| Domain | NAC | 6.44e-05 | 5 | 48 | 2 | SM01407 | |
| Domain | VCX/VCY1 | 6.44e-05 | 5 | 48 | 2 | IPR026653 | |
| Domain | VCX_VCY | 6.44e-05 | 5 | 48 | 2 | PF15231 | |
| Domain | NAC | 9.64e-05 | 6 | 48 | 2 | PF01849 | |
| Domain | Nas_poly-pep-assoc_cplx_dom | 9.64e-05 | 6 | 48 | 2 | IPR002715 | |
| Domain | NAC_AB | 9.64e-05 | 6 | 48 | 2 | PS51151 | |
| Domain | Rho_GTPase_activation_prot | 1.50e-03 | 88 | 48 | 3 | IPR008936 | |
| Domain | UBIQUITIN_1 | 4.07e-03 | 37 | 48 | 2 | PS00299 | |
| Domain | UBA | 6.49e-03 | 47 | 48 | 2 | PS50030 | |
| Domain | WW | 6.49e-03 | 47 | 48 | 2 | PF00397 | |
| Domain | WW | 6.77e-03 | 48 | 48 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 7.61e-03 | 51 | 48 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 7.61e-03 | 51 | 48 | 2 | PS01159 | |
| Domain | WW_dom | 7.90e-03 | 52 | 48 | 2 | IPR001202 | |
| Domain | UBIQUITIN_2 | 8.50e-03 | 54 | 48 | 2 | PS50053 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 7.75e-09 | 281 | 51 | 8 | 28706196 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25637608 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18950703 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12406326 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 33786814 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 28653891 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18076704 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12938160 | ||
| Pubmed | The alpha and beta subunit of the nascent polypeptide-associated complex have distinct functions. | 6.32e-06 | 3 | 51 | 2 | 10982809 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 20214399 | ||
| Pubmed | 1.05e-05 | 197 | 51 | 5 | 36604605 | ||
| Pubmed | 1.17e-05 | 347 | 51 | 6 | 17114649 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 17081159 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 26085624 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 10903929 | ||
| Pubmed | CEP350 ZBTB44 MIA2 ANK2 ANKS1B SMARCE1 GRIN2B ADAM22 DYNC1I1 IQGAP1 | 1.47e-05 | 1285 | 51 | 10 | 35914814 | |
| Pubmed | An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. | 3.15e-05 | 6 | 51 | 2 | 16642035 | |
| Pubmed | Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum. | 3.15e-05 | 6 | 51 | 2 | 25762721 | |
| Pubmed | HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data. | 3.15e-05 | 6 | 51 | 2 | 27086506 | |
| Pubmed | MEK drives BRAF activation through allosteric control of KSR proteins. | 4.41e-05 | 7 | 51 | 2 | 29433126 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 33000527 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 26609151 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.01e-05 | 934 | 51 | 8 | 33916271 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 7.09e-05 | 150 | 51 | 4 | 28242625 | |
| Pubmed | 7.44e-05 | 963 | 51 | 8 | 28671696 | ||
| Pubmed | Anchoring and scaffold proteins for kinases and phosphatases. | 7.54e-05 | 9 | 51 | 2 | 9238861 | |
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 7.54e-05 | 9 | 51 | 2 | 27325115 | |
| Pubmed | 8.47e-05 | 157 | 51 | 4 | 30186101 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 11807172 | ||
| Pubmed | Nudel binds Cdc42GAP to modulate Cdc42 activity at the leading edge of migrating cells. | 1.15e-04 | 11 | 51 | 2 | 18331715 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.26e-04 | 332 | 51 | 5 | 32786267 | |
| Pubmed | p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling. | 1.38e-04 | 12 | 51 | 2 | 16537434 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 35659652 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.63e-04 | 351 | 51 | 5 | 38297188 | |
| Pubmed | 1.78e-04 | 568 | 51 | 6 | 9110174 | ||
| Pubmed | A "double adaptor" method for improved shotgun library construction. | 1.89e-04 | 574 | 51 | 6 | 8619474 | |
| Pubmed | 2.05e-04 | 1116 | 51 | 8 | 31753913 | ||
| Pubmed | 2.08e-04 | 1429 | 51 | 9 | 35140242 | ||
| Pubmed | 2.17e-04 | 79 | 51 | 3 | 25921334 | ||
| Pubmed | 2.35e-04 | 1139 | 51 | 8 | 36417873 | ||
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 14743444 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.57e-04 | 608 | 51 | 6 | 36089195 | |
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 2.83e-04 | 17 | 51 | 2 | 12368262 | |
| Pubmed | 2.95e-04 | 399 | 51 | 5 | 37536630 | ||
| Pubmed | 3.09e-04 | 403 | 51 | 5 | 30562941 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 3.35e-04 | 639 | 51 | 6 | 23443559 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 3.36e-04 | 1201 | 51 | 8 | 35696571 | |
| Pubmed | Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. | 3.55e-04 | 19 | 51 | 2 | 16919237 | |
| Pubmed | Emergence of young human genes after a burst of retroposition in primates. | 3.94e-04 | 20 | 51 | 2 | 16201836 | |
| Pubmed | 3.94e-04 | 20 | 51 | 2 | 22504172 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.15e-04 | 430 | 51 | 5 | 35044719 | |
| Pubmed | 4.87e-04 | 104 | 51 | 3 | 9205841 | ||
| Pubmed | 5.07e-04 | 251 | 51 | 4 | 27507650 | ||
| Pubmed | 6.19e-04 | 25 | 51 | 2 | 15121898 | ||
| Pubmed | 7.23e-04 | 27 | 51 | 2 | 24550280 | ||
| Pubmed | 7.77e-04 | 494 | 51 | 5 | 26831064 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 7.78e-04 | 28 | 51 | 2 | 31600191 | |
| Pubmed | 8.04e-04 | 1371 | 51 | 8 | 36244648 | ||
| Pubmed | 1.05e-03 | 529 | 51 | 5 | 14621295 | ||
| Pubmed | 1.06e-03 | 1431 | 51 | 8 | 37142655 | ||
| Pubmed | 1.11e-03 | 1442 | 51 | 8 | 35575683 | ||
| Pubmed | Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases. | 1.15e-03 | 34 | 51 | 2 | 16611982 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 1.35e-03 | 327 | 51 | 4 | 15592455 | |
| Pubmed | 1.36e-03 | 1487 | 51 | 8 | 33957083 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.36e-03 | 37 | 51 | 2 | 27565344 | |
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 1.43e-03 | 38 | 51 | 2 | 36674791 | |
| Pubmed | 1.43e-03 | 151 | 51 | 3 | 17043677 | ||
| Interaction | AGAP2 interactions | 8.25e-07 | 210 | 50 | 7 | int:AGAP2 | |
| Interaction | FAM153CP interactions | 2.34e-06 | 11 | 50 | 3 | int:FAM153CP | |
| Interaction | ROPN1 interactions | 1.58e-05 | 61 | 50 | 4 | int:ROPN1 | |
| Interaction | DCTN1 interactions | 2.79e-05 | 497 | 50 | 8 | int:DCTN1 | |
| Interaction | FAM153B interactions | 4.51e-05 | 28 | 50 | 3 | int:FAM153B | |
| Cytoband | 7q21 | 9.36e-05 | 13 | 51 | 2 | 7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 1.04e-03 | 178 | 51 | 3 | chr7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q21 | 5.27e-03 | 97 | 51 | 2 | chr14q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p11 | 5.92e-03 | 103 | 51 | 2 | chr8p11 | |
| GeneFamily | Variable charge X/Y family | 4.53e-05 | 6 | 32 | 2 | 368 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.20e-03 | 29 | 32 | 2 | 396 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.53e-03 | 50 | 32 | 2 | 721 | |
| GeneFamily | PHD finger proteins | 1.10e-02 | 90 | 32 | 2 | 88 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | 1.16e-05 | 407 | 50 | 7 | M2214 | |
| Coexpression | GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP | 3.41e-05 | 194 | 50 | 5 | M5136 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 3.94e-05 | 200 | 50 | 5 | M9459 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-08 | 182 | 51 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-08 | 184 | 51 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-08 | 185 | 51 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 180 | 51 | 5 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-06 | 182 | 51 | 5 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-06 | 183 | 51 | 5 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 187 | 51 | 5 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 187 | 51 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 51 | 5 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 190 | 51 | 5 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 194 | 51 | 5 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-06 | 196 | 51 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 198 | 51 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.13e-06 | 198 | 51 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 198 | 51 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 198 | 51 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 198 | 51 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.28e-06 | 200 | 51 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.28e-06 | 200 | 51 | 5 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 3.06e-05 | 156 | 51 | 4 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.30e-05 | 159 | 51 | 4 | ebd840ac2b07e62086ee7b5bb01c21804a0fdc7b | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-05 | 164 | 51 | 4 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 173 | 51 | 4 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 4.90e-05 | 176 | 51 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 4.90e-05 | 176 | 51 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.01e-05 | 177 | 51 | 4 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 5.12e-05 | 178 | 51 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-05 | 180 | 51 | 4 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-05 | 181 | 51 | 4 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-05 | 181 | 51 | 4 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 182 | 51 | 4 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-05 | 185 | 51 | 4 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.95e-05 | 185 | 51 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.95e-05 | 185 | 51 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-05 | 185 | 51 | 4 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 186 | 51 | 4 | aeac0c2db173cd1ea45b5052ab418d6cacd198d8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-05 | 186 | 51 | 4 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.07e-05 | 186 | 51 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.20e-05 | 187 | 51 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 187 | 51 | 4 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.20e-05 | 187 | 51 | 4 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.20e-05 | 187 | 51 | 4 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-05 | 188 | 51 | 4 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-05 | 188 | 51 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 189 | 51 | 4 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 189 | 51 | 4 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 6.46e-05 | 189 | 51 | 4 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 189 | 51 | 4 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 190 | 51 | 4 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 6.59e-05 | 190 | 51 | 4 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.59e-05 | 190 | 51 | 4 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 190 | 51 | 4 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-05 | 192 | 51 | 4 | 2f1c4ef693515ccc7231bd8c6641fad51d445d20 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 51 | 4 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 51 | 4 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.87e-05 | 192 | 51 | 4 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 193 | 51 | 4 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 193 | 51 | 4 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 194 | 51 | 4 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.15e-05 | 194 | 51 | 4 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 194 | 51 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | (4)_Endothelial_cells-(4)_Lymph_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.15e-05 | 194 | 51 | 4 | 9735b86d3b2480a0b34d8aab8e7bd609d83c2454 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.15e-05 | 194 | 51 | 4 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.15e-05 | 194 | 51 | 4 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 194 | 51 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 7.29e-05 | 195 | 51 | 4 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 7.29e-05 | 195 | 51 | 4 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.29e-05 | 195 | 51 | 4 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 196 | 51 | 4 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | primary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.44e-05 | 196 | 51 | 4 | 8efc2b3a95f57c31be203ac781b2098d4909297f | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 196 | 51 | 4 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.44e-05 | 196 | 51 | 4 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.73e-05 | 198 | 51 | 4 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-05 | 198 | 51 | 4 | fef9a4c96450078527b94d25e681410e4ea01b13 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.73e-05 | 198 | 51 | 4 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.73e-05 | 198 | 51 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 7.89e-05 | 199 | 51 | 4 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 7.89e-05 | 199 | 51 | 4 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 7.89e-05 | 199 | 51 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.89e-05 | 199 | 51 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-Treg|Bac-SEP / Disease, condition lineage and cell class | 7.89e-05 | 199 | 51 | 4 | e0b6136e28b813299b7ffbe37f1cf830e60cd7d8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | c59f262b2b0a7e7dcb2940d1e466f98db6c56625 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | e50ef394e3284a8323bfd60575b262b2be422aea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Cortical_neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-05 | 200 | 51 | 4 | 6f7ff0533339fcc9d316f2c77334a79c1409ec4f | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-04 | 119 | 51 | 3 | 0cebbd44378c212aa0e18e4303f09eb315d02e11 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.54e-04 | 131 | 51 | 3 | c847dcdfb94feb9e1dfc072a162d2b1b6f3d59e4 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 5.50e-04 | 140 | 51 | 3 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.74e-04 | 142 | 51 | 3 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-04 | 147 | 51 | 3 | 64fa0753a3a79f492ef8acc6942bf90d379a983f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 6.60e-04 | 149 | 51 | 3 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-04 | 149 | 51 | 3 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.86e-04 | 151 | 51 | 3 | 0b6b37734430918378ed94e40877f0c4ae9b25ec | |
| ToppCell | Severe_COVID-19-undefined|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.86e-04 | 151 | 51 | 3 | 2ae403417fcb3fe402f6f47bb60ffa68d5fefd2a | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.86e-04 | 151 | 51 | 3 | 30225a1a7800b0ae19e16ac164f561379eedb99d | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-Treg|Bac-SEP / Disease, Lineage and Cell Type | 6.86e-04 | 151 | 51 | 3 | 5df5e754a45b8a592ca7ad49a70953be1615066a | |
| ToppCell | Severe_COVID-19-undefined-undefined|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.86e-04 | 151 | 51 | 3 | b402185dd7a93c6d0ec5c4d84d5031a157ee8cfb | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.78e-06 | 195 | 51 | 6 | 4712_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.06e-06 | 197 | 51 | 6 | 3831_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.37e-06 | 199 | 51 | 6 | 4725_DN | |
| Drug | anacardic acid | 4.12e-05 | 30 | 51 | 3 | CID000167551 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 5.53e-05 | 183 | 51 | 5 | 4732_UP | |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; PC3; HT_HG-U133A | 6.13e-05 | 187 | 51 | 5 | 5854_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.28e-05 | 188 | 51 | 5 | 6735_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 6.44e-05 | 189 | 51 | 5 | 6649_DN | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 4411_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 5881_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 5435_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 6821_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 3429_DN | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 4403_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 6792_DN | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 5252_UP | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 6384_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 2845_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 3895_DN | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 7373_DN | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 7461_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 2287_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 2747_UP | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 2063_DN | |
| Drug | nocodazole | 8.85e-05 | 477 | 51 | 7 | CID000004122 | |
| Disease | Neurodevelopmental Disorders | 1.91e-05 | 93 | 50 | 4 | C1535926 | |
| Disease | xanthine measurement | 2.17e-04 | 13 | 50 | 2 | EFO_0010548 | |
| Disease | Adenoid Cystic Carcinoma | 6.59e-04 | 100 | 50 | 3 | C0010606 | |
| Disease | Brain Tumor, Primary | 1.44e-03 | 33 | 50 | 2 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 1.44e-03 | 33 | 50 | 2 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 1.44e-03 | 33 | 50 | 2 | C0750977 | |
| Disease | Neoplasms, Intracranial | 1.44e-03 | 33 | 50 | 2 | C1527390 | |
| Disease | Benign neoplasm of brain, unspecified | 1.44e-03 | 33 | 50 | 2 | C0496899 | |
| Disease | Malignant neoplasm of brain | 1.90e-03 | 38 | 50 | 2 | C0153633 | |
| Disease | Brain Neoplasms | 2.00e-03 | 39 | 50 | 2 | C0006118 | |
| Disease | Malignant neoplasm of breast | 2.11e-03 | 1074 | 50 | 7 | C0006142 | |
| Disease | revision of total hip arthroplasty, aseptic loosening | 2.32e-03 | 42 | 50 | 2 | EFO_0010725, EFO_0020973 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.15e-03 | 49 | 50 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | neuropsychological test | 4.56e-03 | 197 | 50 | 3 | EFO_0003926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VHDITDDGQEETPEI | 131 | Q02952 | |
| HTYLIEPEENDTTQE | 166 | Q9P0K1 | |
| DPTVQESLVSEEIVH | 701 | O94985 | |
| PTIEEQVDQTIDDET | 681 | Q9Y222 | |
| EILETPATSEQEAEH | 1406 | P46940 | |
| EKHDESVTDVTEVPQ | 876 | Q96L93 | |
| VQSVPEEESHRESEV | 2096 | Q01484 | |
| EPVQEDATQETHISS | 296 | Q7Z6G8 | |
| SEEDVVETPAVSHDE | 146 | P11182 | |
| EEIENTSSVQIIEEH | 136 | Q9H2X6 | |
| TEQTISDEEIHDEPE | 746 | P78559 | |
| AEETHVQVQPSTEET | 286 | Q5H9T9 | |
| EVEPTSENEEVHDEA | 611 | Q6VAB6 | |
| QTPLATHQSEEDEED | 171 | O14576 | |
| SDLEDLEEHVPEQTV | 211 | Q9UHL3 | |
| LEEHVPEQTVSEEAT | 216 | Q9UHL3 | |
| ETEETSTQEQSHPGE | 806 | Q76FK4 | |
| KEETELDSEEEQPSH | 1366 | Q92794 | |
| LDSEEEQPSHDTSVV | 1371 | Q92794 | |
| ENSEHSPEVEDVINS | 421 | Q15825 | |
| EVSDDEDETHPNIDT | 11 | Q16543 | |
| SDVEHEQQVTESPSL | 2471 | Q5VT06 | |
| ETSETDHQQPVLSDV | 251 | P24588 | |
| PQESDQTEEHESGIE | 36 | Q8NA54 | |
| SLEQTVEPSEDHSEE | 926 | Q9HC35 | |
| GHITEEEEEVQENSP | 2341 | Q8NDH2 | |
| TTHPEETEEELTEQQ | 546 | Q9UQL6 | |
| SIESPNQEEQEVETD | 231 | Q9Y6Q1 | |
| EDLEEHVPGQTVSEE | 291 | P0C7A2 | |
| EPQTEHQQESESEID | 271 | Q96PC5 | |
| IVSSQEEEEEEQVPT | 131 | Q5VWG9 | |
| QESEVEEPLSQESEV | 156 | Q9H321 | |
| ETEETHLEETTESQQ | 341 | Q969G3 | |
| TDSSQEENEVTEHTP | 296 | O43567 | |
| LTTVEEREPENHAET | 281 | Q96LK8 | |
| PSEEEETAIQVHVDE | 181 | Q8TE82 | |
| PEEEEETVASKQTHI | 2226 | Q6ZRS2 | |
| SEEITEEHSVSENQE | 151 | Q92954 | |
| EEIPEQIANTETTED | 501 | Q15021 | |
| QESEVEEPLSQESEV | 106 | Q9H322 | |
| EPHTSDEEVEQIEAI | 736 | O43295 | |
| SEEEHAIEITTQEIT | 116 | O14662 | |
| DEEVHEEVSQPVSAS | 296 | Q8NCP5 | |
| SHEEVDLELPSTENE | 306 | O75554 | |
| VSQEEEDVTHSVQEP | 871 | Q2M1Z3 | |
| EEDEEHTIITDTELP | 31 | P10646 | |
| VHEEVHEPEEVQEDT | 26 | P45378 | |
| HELNTSEIEEEEDPL | 166 | Q8IWV8 | |
| ETVRPEEVSQEHIET | 16 | Q86UV5 | |
| TLQSPHIEEEETTSI | 151 | Q14202 | |
| NTQTPTVQEESEEEE | 156 | Q9H009 | |
| QTPTVQEESEEEEVD | 2021 | E9PAV3 | |
| NTQTPTVQEESEEEE | 156 | Q13765 | |
| PETEEQEDDHLSIVT | 396 | Q13224 |